Amphix Bio, Inc. recently received a Breakthrough Device designation from the FDA for our lead product -- an exciting step as we move our therapeutic platform closer to clinical trials. Shoutout to our team, Hussain Sangji, PhD, Charlotte Chen, and Iwona Maciagiewicz for this milestone, and thanks to Crain's Chicago Business for the feature!
关于我们
- 网站
-
https://www.amphixbio.com/
Amphix Bio, Inc.的外部链接
- 所属行业
- 纳米技术研究
- 规模
- 2-10 人
- 总部
- Chicago，IL
- 类型
- 私人持股
地点
-
主要
获取路线
US，IL，Chicago，60607